<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1621">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04530539</url>
  </required_header>
  <id_info>
    <org_study_id>2020-68</org_study_id>
    <nct_id>NCT04530539</nct_id>
  </id_info>
  <brief_title>The Effect of Melatonin and Vitamin C on COVID-19</brief_title>
  <official_title>The Effect of Melatonin and Vitamin C on COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lancaster General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lancaster General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double-blind placebo controlled trial that seeks to evaluate the impact of
      melatonin and vitamin C on symptoms and outcomes of patients with COVID-19.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 18, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Symptom Severity</measure>
    <time_frame>14 days</time_frame>
    <description>Symptom severity will be tracked electronically</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptom progression</measure>
    <time_frame>14 days</time_frame>
    <description>Determine symptom course of those with moderate or severe symptoms</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Covid19</condition>
  <condition>SARS-CoV Infection</condition>
  <arm_group>
    <arm_group_label>Experimental- Melatonin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive melatonin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental- Vit C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive vitamin C</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin C</intervention_name>
    <description>1000mg Vitamin C, at bedtime</description>
    <arm_group_label>Experimental- Vit C</arm_group_label>
    <other_name>ascorbic acid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>melatonin</intervention_name>
    <description>10mg melatonin, at bedtime</description>
    <arm_group_label>Experimental- Melatonin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo at bedtime</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Symptom Survey</intervention_name>
    <description>Daily symptom survey to be completed by patient electronically</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Experimental- Melatonin</arm_group_label>
    <arm_group_label>Experimental- Vit C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  COVID-19 positive test (outpatient testing),

          -  Age &gt;50 (chosen based greater risk for older patients to be vitamin deficient, age &gt;65
             not used so as not to be too restrictive in the inclusion criteria)

          -  Experiencing symptoms for &lt;5 days prior to enrollment

          -  Able to read and write in English or Spanish

          -  Able to access REDCap daily

          -  Valid email address

          -  Current has a Lancaster General Health primary care physician

        Exclusion Criteria

          -  COVID-19 test ordered pre-procedure for asymptomatic screening

          -  Currently taking vitamin C supplements

          -  Currently taking melatonin supplements

          -  Currently hospitalized

          -  Deceased

          -  Currently pregnant

          -  Currently incarcerated
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Corey Fogleman</last_name>
    <role>Principal Investigator</role>
    <affiliation>Penn Medicine Lancaster General Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Corey Fogleman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Physician</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tawnya Vernon</last_name>
    <phone>7175447395</phone>
    <email>tawnya.vernon@pennmedicine.upenn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ca Forney</last_name>
    <phone>7175441402</phone>
    <email>Cathleen.Forney@pennmedicine.upenn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lancaster General Health</name>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <zip>17602</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Cathleen Forney</last_name>
      <phone>717-544-1402</phone>
      <email>Cathleen.Forney@pennmedicine.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tawnya Vernon</last_name>
      <phone>7175447395</phone>
      <email>Tawnya.Vernon@pennmedicine.upenn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Corey Fogleman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Donna Cohen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jennifer Rutz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Farrell, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alison Mercier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 26, 2020</study_first_submitted>
  <study_first_submitted_qc>August 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>September 14, 2020</last_update_submitted>
  <last_update_submitted_qc>September 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin c</keyword>
  <keyword>melatonin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

